Deficiency or dysfunction of CYP7A1 can lead to significant clinical consequences. One such condition is hypercholesterolemia, where excessive cholesterol accumulates in the blood, increasing the risk of cardiovascular diseases. Additionally, a deficiency can lead to a reduction in bile acid production, impairing fat digestion and nutrient absorption, potentially resulting in malabsorption syndromes.
